Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis

Name: Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis
Creator: Marc Krause
Published: 2018-11-08T08:51:22.638Z
Keywords: Drugs

Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Schneider-Thoma, Johannes; Bighelli, Irene; Chaimani, Anna; Leucht, Stefan

doi:10.17632/xr2pfb5hks.1

Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis

Published: 8 November 2018| Version 1 | DOI: 10.17632/xr2pfb5hks.1

Contributors:

Marc Krause, Yikang Zhu, Maximilian Huhn, Johannes Schneider-Thoma, Irene Bighelli, Anna Chaimani, Stefan Leucht

Description

Data of the following publication: Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Schneider-Thoma, Johannes; Bighelli, Irene; Chaimani, Anna; Leucht, Stefan (2018): Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis. In: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 28 (6), S. 659–674. DOI: 10.1016/j.euroneuro.2018.03.008.

Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis

Description

Files

Categories

Licence